Concepedia

Ying Z. Mazzu

YZ

14

Publications

568

Citations

13

H-Index

2016

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Molecular Oncology (United States)

Moffitt Cancer Center

Harvard University

Ying Z. Mazzu is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, tumor biology, and systems biology.

ORCID

Top concepts

Publications per year

2016–2022

14

Publications

14

A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)

Ying Z. Mazzu, Joshua Armenia, Goutam Chakraborty et al. · Clinical Cancer Research · 2019 · 164 citations · Full text

ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D

Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura et al. · Journal of Clinical Investigation · 2018 · 74 citations · Full text

, , +20

miR-193b–Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells

Ying Z. Mazzu, Yulan Hu, Rajesh K. Soni et al. · Cancer Research · 2017 · 56 citations

The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer

Goutam Chakraborty, Subhiksha Nandakumar, Rahim Hirani et al. · Clinical Cancer Research · 2022 · 48 citations · Full text

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar et al. · Molecular Oncology · 2020 · 41 citations · Full text

, , +16

Rows per page

1–5 of 14